EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹140 Cr | ₹160 Cr | ₹138 Cr | ₹113 Cr | ₹77 Cr |
What is the latest Total Current Liabilities ratio of EVEREST ORGANICS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹140 Cr |
| Mar2024 | ₹160 Cr |
| Mar2023 | ₹138 Cr |
| Mar2022 | ₹113 Cr |
| Mar2021 | ₹77 Cr |
How is Total Current Liabilities of EVEREST ORGANICS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹140 Cr | -12.55 | |
| Mar2024 | ₹160 Cr | 16.30 | |
| Mar2023 | ₹138 Cr | 22.23 | |
| Mar2022 | ₹113 Cr | 45.50 | |
| Mar2021 | ₹77 Cr | - | |
Compare Total Current Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹273.9 Cr | -5.6% | -9.8% | -32% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -5.6% |
-9.8% |
-32% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses